This Weight Loss Drug Loophole Is Set to Make Investors Incredibly Wealthy
Thanks to this rare FDA loophole, the world's most in-demand weight loss drugs have effectively just gone "off patent" for a short amount of time... Creating a once-in-a-lifetime profit window for investors.
| Open | 71.33 | Prev Close | 70.39 |
| High | 71.40 | Low | 69.30 |
| Volume | 2,312,364 | Volume (Avg) | 2,028,780 |
| 52 Week High | 110.37 | 52 Week Low | 62.48 |
| Market Cap | 17.2B | PE Ratio | 129.98 |
General
| Name | Incyte Corporation |
| Ticker | INCY |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Currency | USD |
| Country | USA |
| Fiscal Year End | December |
| Full Time Employees | 1,773 |
About Incyte Corporation
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera cancers; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor for the treatment of adults; and ICLUSIG, a kinase inhibitor to treat chronic myeloid leukemia and philadelphia-chromosome positive acute lymphoblastic leukemia. Its clinical stage products include ruxolitinib, a drug that is in Phase III clinical trial for steroid-refractory chronic graft-versus-host-diseases (GVHD); itacitinib, which is in Phase III clinical trial to treat naïve chronic GVHD; and pemigatinib that is in Phase II clinical trial for treating bladder cancer, cholangiocarcinoma, 8p11 myeloproliferative syndrome, and Tumor agnostic. In addition, the company engages in developing Parsaclisib, which is in Phase II clinical trial for follicular lymphoma, marginal zone lymphoma, and mantel cell lymphoma. Additionally, the company develops Retifanlimab that is in Phase II clinical trials for MSI-high endometrial cancer, merkel cell carcinoma, and anal cancer, as well as in Phase II clinical trials for patients with non-small cell lung cancer. It has collaboration agreements with Novartis International Pharmaceutical Ltd.; Eli Lilly and Company; Agenus Inc.; Calithera Biosciences, Inc; MacroGenics, Inc.; Merus N.V.; Syros Pharmaceuticals, Inc.; Innovent Biologics, Inc.; Zai Lab Limited; and Cellenkos, Inc., as well as clinical collaborations with MorphoSys AG and Xencor, Inc. to investigate the combination of tafasitamab, plamotamab, and lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma, and relapsed or refractory follicular lymphoma. The company was incorporated in 1991 and is headquartered in Wilmington, Delaware.
Highlights
| Analyst Target | 105.38 |
| Market Cap | 17,202,792,448 |
| PE Ratio | 129.98 |
| PEG Ratio | 0.87 |
| EBITDA | 466,960,992 |
Valuation
| Trailing PE | 47.64 |
| Forward PE | 24.63 |
| Price/Sales (Trailing 12 Mt.) | 6.56 |
| Price/Book (Most Recent Quarter) | 6.76 |
Technicals
| Beta | 0.77 |
| 52 Week High | 110.37 |
| 52 Week Low | 62.48 |
| 50 Day Average | 83.41 |
| 200 Day Average | 86.97 |
Earnings
Elon Musk's Mother Does Harris Impression During TV Appearance
Maye Musk, mother of Elon Musk, has sparked a flurry of reactions following her controversial imitation of Kamala Harris on Fox Business.
Austria says Russia's Gazprom will cut off natural gas supply this weekend
VIENNA (AP) — Russia’s state-owned natural gas company Gazrom will cut off supplies to Austria’s OMV utility early Saturday, Austria’s chancellor said, adding that his country’s underground gas storage was full and that it had alternative, non-Russia supplies.
What Does Trump's Presidency Mean for Elon Musk's AI Venture? - Ad
As new allies, Trump and Musk could reshape America's AI future. Elon Musk's AI startup, xAI, might gain the edge it needs to dominate the industry. A shift in government support, fewer barriers, and a potential "backdoor" into the AI race are just the beginning. Is xAI set to become Elon's most powerful venture yet?
Stock Of The Day: Is Pfizer Set Up To Rally?
Shares of Pfizer (PFE) may be about to reverse and head higher. They are both oversold and at a support level.
Mark Cuban's Million-Dollar Advice To Teens: 'If I Were 16 Again, I'd Start This Lucrative Side Hustle'
Mark Cuban says that the potential of AI could offer the ideal side hustle for teenagers.
Elon Musk: "AI Will Run Out of Electricity ... in 2025" - Ad
This AI boom is going to push America's power grid to the brink... Elon Musk even recently said that AI could run out of electricity by 2025. This crisis may just reveal one of the greatest investment ideas we are ever going to find. My research has recently uncovered two companies that could make a massive difference today.
Man who stole and laundered roughly $1B in bitcoin is sentenced to 5 years in prison
WASHINGTON (AP) — A computer expert who stole worth billions of dollars at current prices — and then spent years laundering some of the hacked cryptocurrency with help from his wife — was sentenced on Thursday to five years in prison.
Wall Street's Most Accurate Analysts Give Their Take On 3 Tech And Telecom Stocks With Over 4% Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks.
Seven Unknown AI Stocks That Could Dominate the Next Six Years - Ad
The original "Magnificent Seven" stocks generated 16,800% over the last 20 years. But now a new set of AI stocks is set to take over. Alex Green dubs them "The Next Magnificent Seven." And he's arguing that just $1,000 in each could turn into more than $1 million in less than six years.
One Tech Tip: Replacing passwords with passkeys for an easier login experience
LONDON (AP) — If you're tired of memorizing passwords, then give passkeys a try.
Ted Cruz Says Running DOGE Won't Be A Cake Walk, Offers Reading Advice To Elon Musk
Senator Ted Cruz (R-Texas) anticipated the newly established Department of Government Efficiency (DOGE) department to yield “good results” but warned that Elon Musk and Vivek Ramaswamy would have their work cut out.
Have You Heard of Donald Trump's Project Crypto? - Ad
Donald Trump aims to be America's first crypto president. Declaring at the Bitcoin conference in Nashville that the U.S. would become ..."the crypto capital of the planet." But, there's a special coin he hasn't mentioned that could soar even higher.
What to stream: 'The Piano Lesson,' 'Wicked' album, 'Spellbound' and 'Cruel Intentions' TV series
Ariana Grande and Cynthia Erivo teaming up for the soundtrack to the upcoming movie “Wicked” and a TV series based on the 1999 film “Cruel Intentions” are some of the new television, films, music and games near you.
Japan's SoftBank returns to profit after gains at Vision Fund and other investments
TOKYO (AP) — Japanese technology group SoftBank swung back to profitability in the July-September quarter, boosted by positive results in its Vision Fund investments.
The Only Defense Stock You Should Be Watching - Ad
In multiple wargames, U.S. forces were overwhelmed and unable to stop Chinese amphibious assaults from seizing the island. With tensions at a boiling point, the economic fallout could be devastating. Get the details on the weapons makers set to boom if war breaks out.
Fighting conspiracy theories with comedy? That's what the Onion hopes after its purchase of Infowars
Headlines from the satirical website the Onion on Thursday: “New Dating Site Suggests People You Already Know But Thought You Were Too Good For.” “Trump Boys Have Slap Fight Over Who Gets to Run Foreign Policy Meetings.” “Here's Why I Decided to Buy Infowars.”
China's president will unveil a megaport in Peru, but locals say they're being left out
CHANCAY, Peru (AP) — On the edge of Peru’s coastal desert, a remote fishing town where a third of all residents have no running water is being transformed into a to cash in on the inexorable rise of .
Shocking Footage from Bill Gates' $100 Billion AI Project - Ad
Jeff Brown flew to Wisconsin to witness Bill Gates' $100 billion AI project firsthand. What he uncovered will blow your mind!
Facebook and Instagram users in Europe can opt for less personalized ads
LONDON (AP) — Facebook and Instagram users in Europe will get the option to see less personalized ads if they don't want to pay for an , social media company Meta said Tuesday, bowing to pressure from Brussels over digital competition concerns.
23andMe cuts 40% of its workforce and discontinues therapeutics division
NEW YORK (AP) — is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the struggling genetic testing company attempts to slash costs.
How Musk & Trump Could Launch These Stocks Higher - Ad
Tesla (TSLA) stock has surged. But the real opportunity? Musk's AI venture, xAI. With Trump's presidency, xAI could soon lead the AI race, backed by strong government connections and fewer regulatory barriers. This powerhouse collaboration could fuel massive growth in the AI sector, and xAI may become Elon's biggest company yet.
Engines on 1.4 million Honda vehicles might fail, so US regulators open an investigation
DETROIT (AP) — The U.S. government's highway safety agency is investigating complaints that on as many as 1.4 million Honda and Acura vehicles.
Pentagon Officials Weigh Responses To Possible Illegal Orders Under Trump
As President-elect Donald Trump prepares to take office for the second time, Pentagon officials are reportedly strategizing their response to potential controversial orders.
Sam Altman, Bill Gates and More Are Making Some Strange Investments - Ad
As a Silicon Valley insider, Michael Robinson's uncovered an even bigger story than AI... A mysterious investment that could be the savior of the tech industry. Big Tech executives -- including Sam Altman, Bill Gates and Mark Zuckerberg -- are throwing large sums of money at it. This is the next frontier of tech investing...
What to know about the congressional push to expand some Social Security benefits
WASHINGTON (AP) — The House has passed legislation that would full Social Security benefits to millions of people, pushing it one step closer to becoming law.
European committee takes a second look at Alzheimer's drug and now says it should be approved
A European regulatory committee now recommends approval of the Alzheimer’s treatment lecanemab a few months after .
The Secret Weapon You Need for This Bull Market - Ad
There's a powerful tool that can remove all the guesswork from trading. It's built to trade the key levels for you, buying dips and selling at the right time, without you having to lift a finger. For a limited time, the creators of this incredible tool are holding a free Workshop where you can see the software in action.
Natural gas flares sparked 2 wildfires in North Dakota, state agency says
BISMARCK, N.D. (AP) — Natural gas flares at oil wells sparked two earlier this fall, according to reports from the North Dakota Fire Marshal's Office.
Man pleads guilty to stealing millions from major Detroit nonprofit
DETROIT (AP) — A man from a Detroit nonprofit group pleaded guilty Friday to financial crimes that stunned the organization and forced some delays in a major riverfront project.
The Real Hillbilly Elegy - Ad
Obama and Biden's "War on Coal" has left nothing but devastation in its wake. In the beautiful hill-towns of Appalachia, unemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. But in a strange twist of fate, something incredible is taking place. A breakthrough that could end America's energy woes and send one government-backed stock climbing.
MLBPA, FanDuel settle lawsuit over alleged improper use of name, image and likeness
NEW YORK (AP) — A commercial affiliate of the Major League Baseball Players Association settled a lawsuit with FanDuel on Friday over the alleged unauthorized use of the names and images of MLB players on its sports-betting platform.
UK hits Iran with new sanctions for supplying missiles to Russia
LONDON (AP) — The U.K. government hit Iran with new sanctions Monday for sending ballistic missiles and other weapons to Russia to support against Ukraine.
[Breaking] Classified Wargames Reveal Grave Threat From China - Ad
In multiple wargames, U.S. forces were overwhelmed and unable to stop Chinese amphibious assaults from seizing the island. With tensions at a boiling point, the economic fallout could be devastating. Get the details on the weapons makers set to boom if war breaks out.
Gaetz Nomination In Peril Due To GOP Resistance
Matt Gaetz's nomination for attorney general may already be in trouble due to resistance from members of his own party.
Dogecoin Explodes For 86% Weekly Gain: What Is Going On?
Dogecoin's (CRYPTO: DOGE) monster rally has traders speculating about elevated price targets.
Why Trump's Victory Could Fuel the Next AI Surge - Ad
Louis Navellier, tech investor and market veteran, believes Trump's return will drive a second AI boom. Get the top six stocks he recommends before they skyrocket.
Chinese hackers target Tibetan websites in malware attack, cybersecurity group says
BANGKOK (AP) — A hacking group that is believed to be has compromised two websites with ties to the Tibetan community in an attack meant to install malware on users' computers, according to findings released Wednesday by a private cybersecurity firm.
The state that cleared the way for sports gambling now may ban 'prop' bets on college athletes
TRENTON, N.J. (AP) — After an unexpected loss in which he threw four interceptions in September, Auburn quarterback Payton Thorne heard from bettors angry that his subpar statistics lost bets for them. Some contacted him over the Venmo cash transfer app, asking him to refund their losses.
Former Medical Student Turned Hedge Fund Extraordinaire Discovers New Weight Loss Drug Profit Window - Ad
A unique FDA loophole has opened up a chance for everyday investors to 4X their money in 12 months...
Bitcoin May End The Year At $79,000, Economist Predicts--But Here's How Different Election Outcomes Could Change That
Economist and trader Alex Krüger on Friday laid out his price predictions for Bitcoin (CRYPTO: BTC) based on the 2024 U.S.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.